Vasundhara Rasayans Ltd (VRL) — shareholding pattern, promoter holding, financials and share price
About Vasundhara Rasayans Ltd (VRL)
Vasundhara Rasayans Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as VRL and on the BSE under scrip code 538634. Its ISIN is INE406F01010.
Incorporated in 1987, Vasundhara Rasayans Ltd is a manufacturer and exporter of Antacids [1]
Vasundhara Rasayans Limited is a leading manufacturer and exporter of Antacids therapeutic category of Active Pharmaceutical Ingredients (API), with an annual capacity of about 1500 MT.
The company's operations started in 1990, and its main manufacturing plant is strategically located between Mumbai and Goa, facilitating ease of export.
Listed peers in Pharmaceuticals: Asston Pharmaceuticals Ltd, Ajooni Biotech Ltd, Vineet Laboratories Ltd, Biofil Chemicals & Pharmaceuticals Ltd, Bacil Pharma Ltd, Kabra Drugs Ltd.
Valuation & Returns
10 Jul 2026At ₹174.91 a share on 10 Jul 2026, Vasundhara Rasayans Ltd (VRL) was valued at a price-to-earnings ratio of 14.63x against an industry P/E of 36.41x and a price-to-book of 1.56x on a book value of ₹111.88 per share as of Mar 2025. Solomo computes return on equity of 10.69% and return on capital employed of 14.06% from filed results. Earnings ratios use standalone results for the twelve months Mar 2025 to Dec 2025.
- P/E
- 14.63x
- Industry P/E
- 36.41x
- P/B
- 1.56x
- EPS (TTM)
- ₹11.96
- Book value / share
- ₹111.88
- ROE
- 10.69%
- ROCE
- 14.06%
- ROA
- 8.82%
- Debt / equity
- 0.12x
- Dividend yield
- 1.14%
- EBITDA margin
- 19.03%
- 52-week range
- ₹100.1 – ₹220
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Vasundhara Rasayans Ltd (VRL) reported revenue of ₹35.72 crore, net profit of ₹5.79 crore and earnings per share of ₹18.22. That compares with revenue of ₹33.99 crore and net profit of ₹4.25 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹11.89 crore and net profit ₹2.48 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 26.7 | 37.88 | 36.96 | 33.99 | 35.72 |
| Net profit (₹ cr) | 2.17 | 5.59 | 5.86 | 4.25 | 5.79 |
| EPS (₹) | 6.83 | 17.59 | 18.44 | 13.37 | 18.22 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 8.39% | 9.81% | 8.31% | -8.18% |
| Profit growth | 37.85% | 7.28% | 25.03% | -27.47% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 61.98% of Vasundhara Rasayans Ltd (VRL) (unchanged from the previous quarter). Market capitalisation was ₹56 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Jun 2014.
Largest disclosed public shareholders in Jun 2026: GARG LEASING AND FINANCE PRIVATE LIMITED 3.55%, INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS Clic 1.46%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 61.98% | - | - | - | 38.02% |
| Mar 2026 | 61.98% | - | - | - | 38.02% |
| Dec 2025 | 61.98% | - | - | - | 38.02% |
| Sep 2025 | 61.98% | - | - | - | 38.02% |
| Jun 2025 | 61.98% | - | - | - | 38.02% |
| Mar 2025 | 61.98% | - | - | - | 38.02% |
| Dec 2024 | 61.98% | - | - | - | 38.02% |
| Sep 2024 | 61.98% | - | - | - | 38.02% |